Indeed, KRAS-mutant cancer cells displayed non-canonical endogenous NF-κΒ activity evident by enhanced nuclear localization and/or DNA-binding activity of RelB, ΙκΒβ, and ΙΚΚα, which was further inducible by exogenous IL-1β. This evidence concerns the gene KRAS and cancer.